Obsessive Compulsive Disorder (OCD) affects 1 in 40 people (2.3% of the population), impacting individuals universally. OCD’s effects can be profound, hindering productivity and fulfillment in life. Although traditional approaches to OCD, primarily centered around psychotherapy and medications, provide benefits to many patients, there is growing scientific and evidence-based research that supports that OCD often arises from discrete biological factors such as genetics, inflammation, gut dysbiosis, and more significantly, serotonergic dysfunction.


PROGRAM FORMAT: Self-paced, online training with guided lectures and live faculty sessions

START DATE & LIVE SESSIONS: Program begins December 12, 2026, with the commencement of the first live session. Live sessions are scheduled for December 12, 15 and 22.

THIS TRAINING IS IDEAL FOR: Psychiatrists and clinicians (MD/DO), nurses and nurse practitioners, therapists, physicians and physician assistants, naturopathic physicians, dietitians, nutritionists, and other health and mental health clinicians. This program is designed as a professional training, but patients and families are welcome to enroll and learn. 

ACCREDITATION: 2.5 CME AMA PRA Category 1 Credits™

ENROLLMENT FEE: $499



Core Clinical Topics

This Training Includes:

Instructors

James Greenblatt, MD

Founder, Chief Medical Officer

Dr. James M. Greenblatt is a pioneer in functional and integrative psychiatry and a board-certified child and adult psychiatrist who has been treating patients since 1988. He serves as an Assistant Clinical Professor of Psychiatry at Tufts University School of Medicine and Dartmouth’s Geisel School of Medicine. An internationally recognized speaker on nutritional interventions in mental health and prolific author, Dr. Greenblatt has written ten books, including his newest books, Finally Hopeful and The Lithium Revolution; and the bestsellers Finally Focused and Answers to Anorexia. He is also the founder of Psychiatry Redefined, an educational platform dedicated to transforming psychiatric care through integrative and evidence-based approaches.

Sharon Hausman-Cohen, MD, FAAFP, ABIHM

Dr. Sharon Hausman-Cohen is the Chief Medical Officer and co-founder of IntellxxDNA.  Dr. Hausman-Cohen has been in the field of integrative medicine for over 25 years and is the co-author of many publications and textbook chapters relating to using genomics to improve outcomes in environmental medicine, mental health, cognitive decline and autism. She is proud that IntellxxDNA is being used in IRB approved studies as well as by well-respected functional medicine trained physicians across the country. She and her co-founder developed IntellxxDNA as an answer to an unmet need in the medical community; the need for an accurate, evidence-based genomics tool geared at helping physicians practice true root cause medicine, whether the patient has mental health concerns, cardiometabolic concerns, cognitive decline or medical mysteries. Dr. Hausman-Cohen received both her master’s degree and medical degree from Harvard Medical School. In addition to supervising the research for IntellxxDNA she practices at Resilient Health in Austin.